1[1]Roberge JN, Brubaker PL. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop[J]. Endocrinology , 1993, 133(1):233～240
2[2]Hansen L, Deacon CF, Orskov C, et al. Glucagon-like peptide-1-(7-36)amide is transformed to glucagons-like peptide-1(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine[J]. Endocrinology 1999,140(11):5356～5363
3[3]Hartmann B, Harr MB, Jeppesen PB. In vivo and in vitro degradation of glucagon-like peptide-2 in humans[J]. J Clin Endocrinol Metab, 2000, 85(8):2884～2888
4[4]Holz GG, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagons-like peptide-(7-37)[J]. Nature 1993, 361(6410):362～365
5[5]Bode HP, Moormann B, Dabew R, et al. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic β-cells independently of protein kinase A[J]. Endocrinology, 1999, 140(8):3919～3927
6[6]Bullock BP, Heller RS, Habener JF. Tissue distribuion of message ribonucleic acid encoding the rat glucagons-like peptide 1 receptor[J]. Endocrinology, 1996, 137(6):2968～2978
7[7]Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and opmaental expression of receptors for glucagons and gllucagon-like peptide-1 in the mouse[J]. Endocrinology, 1994, 134(5):2156～2164
8[8]Sandhu HM Wiesenthal SR, MacDonald PE, et al. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs[J]. Diabetes,1999, 48(5):1045～1053
9[9]Vella A, Shah P, Basu R, et al. Effect of glucagons-like peptide 1 (7-36) amide on glucose effectiveness and insulin action people with type 2 diabetes[J]. Diabetes, 2000, 49(4):611～617
10[10]Szayna M, Doyle ME, Betkey JA, et al. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zukcker rats[J]. Endocrinology, 2000, 141(4): 1936～1941
